Lemonade, Inc. LMND
44.93
(0.35)
(0.77%)
as of 25 Sep
- Market cap
- $3.5B
- P/E
- 0.0×
Follow LMND
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(31.34%) | (29.37%) | (26.12%) | (26.96%) | |
| (9.29%) | (8.77%) | (7.28%) | (7.01%) | ||
ROIC |
(37.14%) | (34.10%) | (26.94%) | (25.59%) | |
Return on Tangible Assets |
109.10% | 124.91% | 85.95% | 65.56% | |
Average Days of Receivables |
312.02 | 274.88 | 256.93 | 233.04 | |
Free Cash Flow per Share |
(0.44) | (0.35) | 0.26 | 0.11 | |
Free Cash Flow |
(32.90) | (25.90) | 19.50 | 8.10 | |
Capital Expenditures |
(9.50) | (9.40) | (10.60) | (13.10) | |
Piotroski F-Score |
4.00 | 4.00 | 6.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(2.32%) | (1.52%) | 2.78% | 1.95% | |
Accounts Receivable Turnover |
1.25 | 1.44 | 1.54 | 1.70 | |
Accounts Payable Turnover |
0.35 | 0.39 | 0.43 | 0.48 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,104.84 | 991.60 | 905.61 | 794.73 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.02) | 0.03 | 0.04 | 0.04 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
51.34% | 49.36% | 46.57% | 44.46% | |
Share Based Compensation of Revenue |
9.13% | 8.31% | 8.55% | 8.34% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.13 | 0.10 | (0.22) | (0.15) | |
Depreciation/Fixed assets |
0.74 | 0.59 | 0.47 | 0.31 | |
Capex/Depreciation |
(0.84) | (1.00) | (1.36) | (2.22) | |
Revenue per Share |
8.88 | 9.98 | 11.07 | 12.67 | |
Operating CF per Share |
(0.32) | (0.22) | 0.39 | 0.28 | |
Capex per Share |
(0.13) | (0.13) | (0.14) | (0.17) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(26.39%) | (22.43%) | (16.44%) | (14.19%) |
Columns are period end dates